🕵️ Chemours Co ($CC)
SEC insider & ownership activity, last 12 months · CIK 1627223 · every row links its SEC filing
Over the last 12 months insiders bought $49K with no open-market selling against it. Dignam Denise bought $49K in discretionary trades (Aug). Blackrock, Inc. trimmed 16.9% → 14.3%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $49K (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Dignam Denise | 1 | $49K | 0 | – | Aug 8, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 14.3% | 13G | Apr 24, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 7.0% | 13G | Apr 29, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.3% | 13G | Apr 29, 2026 | filing ↗ | |
| Millennium Management LLC | 5.1% | 13G | Aug 8, 2025 | filing ↗ | |
| Millennium Group Management LLC | 5.1% | 13G | Aug 8, 2025 | filing ↗ | |
| Israel A. Englander | 5.1% | 13G | Aug 8, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 24, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 24, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 12, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 12, 2026 | filing ↗ |
| Other events (8.01) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Other events (8.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Earnings (2.02) | Feb 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 19, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 15, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 13, 2025 | filing ↗ |
| New financial obligation (2.03) | Oct 13, 2025 | filing ↗ |
| Other events (8.01) | Oct 13, 2025 | filing ↗ |
| Other events (8.01) | Sep 2, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 29, 2025 | filing ↗ |
| Earnings (2.02) | Aug 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing ↗ |